---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: ABVE - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/abve
version: v1
---

# ABVE - NCI

# ABVE

This chemotherapy combination contains the drugs doxorubicin hydrochloride (Adriamycin), bleomycin, vincristine sulfate, and etoposide phosphate. Combinations usually work better than single drugs because
different drugs kill
cancer
cells in different ways.

Drugs in the ABVE combination:

|  |  |
| --- | --- |
| **A** | = [Doxorubicin Hydrochloride](/about-cancer/treatment/drugs/doxorubicinhydrochloride) (Adriamycin) |
| **B** | = [Bleomycin](/about-cancer/treatment/drugs/bleomycin) |
| **V** | = [Vincristine Sulfate](/about-cancer/treatment/drugs/vincristinesulfate) |
| **E** | = [Etoposide Phosphate](/about-cancer/treatment/drugs/etoposidephosphate) |

Each of the
drugs
in this
combination
is approved by the
[Food and Drug
Administration (FDA)](/Common/PopUps/popDefinition.aspx?id=454785&version=Patient&language=English)
to treat cancer or conditions related to
cancer.

## Use in Cancer

ABVE is used to treat:

- **[Hodgkin lymphoma](/Common/PopUps/popDefinition.aspx?id=270800&version=Patient&language=English)** in children.

This combination may also be used with other drugs or treatments or to treat other types of cancer.

## More About ABVE

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/657148) - Detailed scientific definition and other names for this drug.
